Page 191 - Pagetit
P. 191

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   symptomatic manifestations of the same underlying neuropathologies? These
                   are topics of considerable recent interest and research at both the clinical
                   and preclinical levels.
                     The purpose of this chapter is to present several hypotheses that may
                   explain the high degree of comorbidity between mental illness and substance
                   dependence. Emphasis will be placed on the comorbidity of schizophrenia
                   and depression with illicit drug dependence, tobacco smoking and alcohol
                   use, with particular reference to dependence on psychostimulants and
                   tobacco. Schizophrenia and depression were selected on the basis of high
                   societal and economic costs of these two disorders (Rupp & Keith, 1993;
                   Mauskopf et al., 1999; Meltzer, 1999; Wong & Licinio, 2001), and on the fact
                   that they appear to be highly associated with substance use disorders.
                   Generally, research findings over the past decade will be highlighted, although
                   older findings will also be referred to where relevant. Finally, directions for
                   future clinical and preclinical research will be discussed, as well as
                   considerations for treatment and prevention of substance use disorders.
                     It is also important to recognize that the effects of many psychoactive
                   substances can produce psychiatric-like syndromes. For example, as
                   discussed in Chapter 4, amphetamines and cocaine can induce psychotic-
                   like symptoms, and some drugs can produce hallucinations, which are an
                   aspect of some psychoses. Furthermore, psychoactive substances alter mood
                   states, producing either euphoria and feelings of well-being, or inducing
                   depression, especially during substance withdrawal. Psychoactive substances
                   can alter cognitive functioning, which is also a core feature of many mental
                   illnesses. These factors all suggest common neurobiological mechanisms to
                   both mental illnesses and substance dependence.
                     Research into the comorbidity of mental illness with substance dependence
                   will provide new insights into both disorders, and may provide improved
                   treatment and prevention strategies for both disorders independently, and
                   when they co-occur. Research in developing countries, among the general
                   population, and among people seeking or receiving treatment is also of extreme
                   importance for better understaning the relationship between biological and
                   environmental factors related to comorbidity.



                   Hypotheses that may explain the observed comorbidity
                   As discussed above, the high comorbidity between any mental illness and
                   substance dependence in humans in certain populations (Rounsaville et
                   al., 1982; Robins et al., 1984; Rounsaville et al., 1987; Robins & Regier, 1991;
                   Rounsaville et al., 1991; Kessler et al., 1994; Kosten, Markou & Koob, 1998)
                   is likely to reflect similarities in the neurobiology of these psychiatric
                   disorders.
                     Four neurobiological hypotheses can be postulated to explain this
                   comorbidity.


                                                  170




          Chapter_6                170                             19.1.2004, 11:48
   186   187   188   189   190   191   192   193   194   195   196